Skip to main content
Caplight Logo









MyRx

MyRx

Private
HyderabadHealthcare & Life Scienceshttps://myrx.in/

Last Round

Seed

Sep 24, 2026

Momentum

Top 5%

of companies Caplight tracks

Company Overview

MyRx operates in Healthcare & Life Sciences and is based in Hyderabad. Its latest recorded funding round was a Seed round in September 2026.

MyRx is a health tech company that provides a primary healthcare infrastructure platform integrating a doctor network with teleconsultation, electronic prescriptions, and clinical workflow technology.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, EHR & EMR, Vertical SaaS, Patient Engagement

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

MyRx Comparables

Compare MyRx with similar companies based on industry and business-model similarity.

MyRx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Eka Care
78%
Meddo Health
77%
HealthPlix Technologies
75%
Book a demo to see all comparables

For institutional investors. Book with your work email.

MyRx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 24, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Neel R Rath

Co-Founder & CTO

Founding Team

Sourav Das

Founder & CEO

Founding Team

For institutional investors. Book with your work email.

MyRx Investors

Notable investors and investment history

MyRx investors
InvestorRounds
SteerXSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 24, 2026

    Seed round led by SteerX.

  • Sep 2, 2026

    Grew 22% QoQ, from 60 to 73 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

MyRx Filings

Explore SEC and related filing metadata, where available.

MyRx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about MyRx's valuation, stock price, and market status.

Is MyRx a public or private company?

MyRx is a private company.

What is the current stock price of MyRx?

MyRx is a private company, so its shares have no public market price. Caplight tracks MyRx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is MyRx worth (valuation)?

Valuation information for MyRx is not publicly available.

Can I buy MyRx stock?

MyRx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was MyRx's last funding round?

MyRx's most recent funding round was Seed on September 24, 2026.

Who are the main investors in MyRx?

Key investors in MyRx include SteerX.

Will MyRx IPO soon?

No public IPO plans have been announced for MyRx.

How can I track MyRx secondary market activity?

Caplight tracks bids, offers, and trades in MyRx's shares on secondary markets.

Firmographic Details

HeadquartersHyderabad
Employee Range73
Year Founded2019
Last FundingSep 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?